Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT04221477 REGENCY — A Study to Evaluate the Efficacy and Safety of Obinutuzumab i… |
Obinutuzumab | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Brazil, Colombia, France, G… | 2020-08-10 → 2031-03-02 | Ouvrir |
| NCT07175285 BENCHMARK-SLE — A Study in Participants With Active Systemic Lupus Eryt… |
BENCHMARK-SLE — A Study in Partic… | Lupus | À vérifier | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Argentina, Brazil, Canada, France, Ger… | 2025-10-08 → 2032-10-05 | Ouvrir |
| NCT07330245 DAHLIA — Achievement of LLDAS5 in Patients With Systemic Lupus Erythema… |
Anifrolumab | Lupus | À vérifier | RECRUITING | En attente / non publié | AstraZeneca | Italy · AOU Ospedali Riuniti di Ancona - Presidio Tor… | 2025-12-31 → 2028-09-30 | Ouvrir |
| NCT07720310 Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupu… |
CAR T cells chimeric antigen rece… | Lupus | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | N.N. Alexandrov National Cancer C… | Belarus · NN Alexandrov National Cancer Centre of Bel… | 2026-03-09 → 2030-06 | Ouvrir |
| NCT07719322 Non Invasive Assessment of Subclinical Atherosclerosis and Cardiovascul… |
Non Invasive Assessment of Subcli… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Egypt · Assuit university hospitals, Asyut, Egypt | 2026-07 → 2029-07 | Ouvrir |
| NCT07719140 Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonizati… |
High-dose prednisone | Lupus | Phase 4 | RECRUITING | En attente / non publié | Peking Union Medical College Hosp… | China · Beijing Children's Hospital, Capital Medical … | 2026-07 → 2029-03 | Ouvrir |
| NCT06799520 A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics,… |
VIS171 | Lupus | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Otsuka Pharmaceutical Development… | Bulgaria, Moldova, Romania, Spain · Visterra Investig… | 2025-03-17 → 2027-02-19 | Ouvrir |
| NCT07430306 SUNFLOWER — A Study to Evaluate the Treatment Outcomes of Subcutaneous … |
Anifrolumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | AstraZeneca | United States, Canada, France, Germany, Italy, Mexico… | 2026-04-13 → 2029-01-26 | Ouvrir |
| NCT07721324 SLE — Effect of Melatonin Administration on Systemic Lupus Erythematosu… |
Melatonin | Lupus | Phase 2/3 | NOT_YET_RECRUITING | En attente / non publié | Nishtar Medical University | Egypt · Department of Rheumatology Ain Shams Universi… | 2026-07-21 → 2026-11-21 | Ouvrir |
| NCT07721857 Neutrophil Extracellular Traps and Lupus Nephritis |
Neutrophil Extracellular Traps an… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Non communiqué | 2026-09-01 → 2028-10-31 | Ouvrir |
| NCT07721363 OBLUMEN — Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous… |
Obinutuzumab | Lupus | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Hoffmann-La Roche | France · Sorbonne University - Nephrology Départment … | 2026-09-02 → 2029-09-02 | Ouvrir |
| NCT05798117 An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics o… |
YTB323 | Lupus | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | Australia, France, Germany, Spain, Switzerland · Nova… | 2023-02-28 → 2026-09-24 | Ouvrir |
| NCT06217107 Wellness & Workforce Solution for Lupus/Lupus Nephritis |
Wellness & Workforce Solution for… | Lupus | Non applicable | RECRUITING | En attente / non publié | Morehouse School of Medicine | United States · Morehouse School of Medicine, Atlanta… | 2024-09-14 → 2026-12-31 | Ouvrir |
| NCT06627647 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemoth… |
Rilvegostomig | Cancer | Phase 3 | RECRUITING | En attente / non publié | AstraZeneca | United States, Argentina, Australia, Belgium, Brazil,… | 2024-11-27 → 2030-11-18 | Ouvrir |
| NCT06222788 Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer … |
Convertible Plasma Jet | Cancer | Non applicable | RECRUITING | En attente / non publié | Centre hospitalier de l'Universit… | Canada · Centre Hospitalier de l'Université de Montré… | 2025-04-07 → 2028-12 | Ouvrir |
| NCT07062536 mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Can… |
Oxaliplatin, 5FU, leucovorin | Cancer | Phase 2 | RECRUITING | En attente / non publié | Seoul National University Bundang… | South Korea · ASAN Medical Center, Seoul, South Korea… | 2025-08-27 → 2028-04-01 | Ouvrir |
| NCT07056946 Supra Inguinal Fascia Iliaca Block Versus Ultrasound-guided Caudal Anal… |
Supra Inguinal Fascia Iliaca Bloc… | Cancer | Non applicable | COMPLETED | En attente / non publié | National Cancer Institute, Egypt | Egypt · National Cancer institute, Cairo, Egypt | 2025-08-01 → 2026-08-01 | Ouvrir |
| NCT04776941 Expressive Writing for the Management of Stress in Cancer Survivors |
Expressive Writing for the Manage… | Cancer | Non applicable | RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · M D Anderson Cancer Center, Houston, … | 2020-08-07 → 2028-12-31 | Ouvrir |
| NCT06772623 Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telis… |
Telisotuzumab Adizutecan | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | AbbVie | United States, Australia, Belgium, China, France, Ger… | 2025-03-06 → 2027-11 | Ouvrir |
| NCT01953640 PROMOTE — Gene Expression in Patients With Metastatic Prostate Cancer R… |
PROMOTE — Gene Expression in Pati… | Cancer | À vérifier | COMPLETED | En attente / non publié | Mayo Clinic | United States · Mayo Clinic in Arizona, Scottsdale, U… | 2013-05-30 → 2023-04-03 | Ouvrir |
| NCT05014399 Chemo Brain — Cognitive Impairment in Colorectal Cancer Patients Receiv… |
Chemo Brain — Cognitive Impairmen… | Cancer | À vérifier | RECRUITING | En attente / non publié | Joseph McCollom | United States · Parkview Cancer Institute, Fort Wayne… | 2021-09-20 → 2031-10 | Ouvrir |
| NCT06629779 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Meta… |
PF-06821497 | Cancer | Phase 3 | RECRUITING | En attente / non publié | Pfizer | United States, Argentina, Brazil, Bulgaria, Canada, C… | 2024-10-22 → 2028-11-30 | Ouvrir |
| NCT06527157 PROACTION: — Investigations of Reproductive Cancers in Women |
PROACTION: — Investigations of Re… | Cancer | À vérifier | RECRUITING | En attente / non publié | PinkDx, Inc. | United States · Advent Health Orlando, Orlando, Unite… | 2024-07-30 → 2031-11-15 | Ouvrir |
| NCT05231122 Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD… |
Anti-CD40 Agonist Monoclonal Anti… | Cancer | Phase 2 | RECRUITING | En attente / non publié | Roswell Park Cancer Institute | United States · M D Anderson Cancer Center, Houston, … | 2024-03-12 → 2027-03-15 | Ouvrir |
| NCT05043012 Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic … |
flexible AIR coil | Cancer | Non applicable | RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · The University of Texas MD Anderson C… | 2022-07-18 → 2027-02-02 | Ouvrir |